Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Biolinerx, Ltd.

Clinical trials sponsored by Biolinerx, Ltd., explained in plain language.

BioLineRx, Ltd. BLRX NASDAQ

A clinical-stage biopharmaceutical company developing therapies for oncology and immunology.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1

New drug combo aims to boost stem cell harvest in myeloma patients

Disease control Ongoing

This phase 3 trial tests whether adding BL-8040 to standard G-CSF helps collect more stem cells for transplant in multiple myeloma patients. About 180 participants received either the combo or a placebo. The goal is to see if more patients can collect enough cells in fewer sessio…

Phase: PHASE3 • Sponsor: BioLineRx, Ltd. • Aim: Disease control

Last updated Jun 27, 2026 08:11 UTC